Literature DB >> 23443612

Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.

T Langsenlehner1, C Döller, P Winkler, G Gallé, K S Kapp.   

Abstract

PURPOSE: The aim of this work was to analyze interfraction and intrafraction deviations and residual set-up errors (RSE) after online repositioning to determine PTV margins for 3 different alignment techniques in prostate cancer radiotherapy.
METHODS: The present prospective study included 44 prostate cancer patients with implanted fiducials treated with three-dimensional (3D) conformal radiotherapy. Daily localization was based on skin marks followed by marker detection using kilovoltage (kV) imaging and subsequent patient repositioning. Additionally, in-treatment megavoltage (MV) images were obtained for each treatment field. In an off-line analysis of 7,273 images, interfraction prostate motion, RSE after marker-based prostate localization, prostate position during each treatment session, and the effect of treatment time on intrafraction deviations were analyzed to evaluate PTV margins.
RESULTS: Margins accounting for interfraction deviation, RSE and intrafraction motion were 14.1, 12.9, and 15.1 mm in anterior-posterior (AP), superior-inferior (SI), and left-right (LR) direction for skin mark alignment and 9.6, 8.7, and 2.6 mm for bony structure alignment, respectively. Alignment to implanted markers required margins of 4.6, 2.8, and 2.5 mm. As margins to account for intrafraction motion increased with treatment prolongation PTV margins could be reduced to 3.9, 2.6, and 2.4 mm if treatment time was ≤ 4 min.
CONCLUSION: With daily online correction and repositioning based on implanted fiducials, a significant reduction of PTV margins can be achieved. The use of an optimized workflow with faster treatment techniques such as volumetric modulated arc techniques (VMAT) could allow for a further decrease.

Entities:  

Mesh:

Year:  2013        PMID: 23443612     DOI: 10.1007/s00066-012-0303-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  32 in total

1.  Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy.

Authors:  V Prokic; H Geinitz; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  2012-02-16       Impact factor: 3.621

2.  Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.

Authors:  Justus Adamson; Qiuwen Wu; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

3.  Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion.

Authors:  James A Tanyi; Tongming He; Paige A Summers; Ruth G Mburu; Catherine M Kato; Stephen M Rhodes; Arthur Y Hung; Martin Fuss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

4.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

5.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

6.  Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Authors:  Michael Pinkawa; Marc D Piroth; Richard Holy; Victoria Djukic; Jens Klotz; Barbara Krenkel; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-07-25       Impact factor: 3.621

Review 7.  Target definition in prostate, head, and neck.

Authors:  Coen Rasch; Roel Steenbakkers; Marcel van Herk
Journal:  Semin Radiat Oncol       Date:  2005-07       Impact factor: 5.934

8.  Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.

Authors:  Anthony L Zietman; Kyounghwa Bae; Jerry D Slater; William U Shipley; Jason A Efstathiou; John J Coen; David A Bush; Margie Lunt; Daphna Y Spiegel; Rafi Skowronski; B Rodney Jabola; Carl J Rossi
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

9.  Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.

Authors:  Abrahim Al-Mamgani; Wim L J van Putten; Wilma D Heemsbergen; Geert J L H van Leenders; Annerie Slot; Michel F H Dielwart; Luca Incrocci; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

10.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Michael J Zelefsky; Emily J Levin; Margie Hunt; Yoshiya Yamada; Alison M Shippy; Andrew Jackson; Howard I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-15       Impact factor: 7.038

View more
  8 in total

1.  Observation of intrafraction prostate displacement through the course of conventionally fractionated radiotherapy for prostate cancer.

Authors:  Yasushi Hamamoto; Hiroki Inata; Noritaka Sodeoka; Shigeki Nakayama; Shintaro Tsuruoka; Hideki Takeda; Toshiharu Manabe; Teruhito Mochizuki; Masakichi Umeda
Journal:  Jpn J Radiol       Date:  2015-02-08       Impact factor: 2.374

2.  Three-dimensional surface imaging for detection of intra-fraction setup variations during radiotherapy of pelvic tumors.

Authors:  Giuseppina Apicella; Gianfranco Loi; Sara Torrente; Silvia Crespi; Debora Beldì; Marco Brambilla; Marco Krengli
Journal:  Radiol Med       Date:  2016-06-14       Impact factor: 3.469

3.  Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.

Authors:  Cédric M Panje; Alan Dal Pra; Thomas Zilli; Daniel R Zwahlen; Alexandros Papachristofilou; Fernanda G Herrera; Oscar Matzinger; Ludwig Plasswilm; Paul Martin Putora
Journal:  Strahlenther Onkol       Date:  2015-05-19       Impact factor: 3.621

4.  Real-time prostate motion assessment: image-guidance and the temporal dependence of intra-fraction motion.

Authors:  Avilash K Cramer; Amanu G Haile; Sanja Ognjenovic; Tulsee S Doshi; William Matthew Reilly; Katherine E Rubinstein; Nima Nabavizadeh; Thuan Nguyen; Lu Z Meng; Martin Fuss; James A Tanyi; Arthur Y Hung
Journal:  BMC Med Phys       Date:  2013-09-23

5.  Quantification of an external motion surrogate for quality assurance in lung cancer radiation therapy.

Authors:  Jens Wölfelschneider; Tobias Brandt; Sebastian Lettmaier; Rainer Fietkau; Christoph Bert
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

6.  PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.

Authors:  Christoph Oehler; Stephanie Lang; Peter Dimmerling; Christian Bolesch; Stephan Kloeck; Alessandra Tini; Christoph Glanzmann; Yousef Najafi; Gabriela Studer; Daniel R Zwahlen
Journal:  Radiat Oncol       Date:  2014-11-11       Impact factor: 3.481

7.  A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer.

Authors:  Ming Li; Gao-Feng Li; Xiu-Yu Hou; Hong Gao; Yong-Gang Xu; Ting Zhao
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

8.  Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Authors:  Joen Sveistrup; Per Munck af Rosenschöld; Joseph O Deasy; Jung Hun Oh; Tobias Pommer; Peter Meidahl Petersen; Svend Aage Engelholm
Journal:  Radiat Oncol       Date:  2014-02-04       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.